About Us > Company Profile

The HOB Story

HOB Biotech Group is a leading manufacturer in China and has emerged as a first-class global company in allergy and autoimmune in vitro diagnostics.

In 2007, entrepreneurs with education and decades of industrial experience in the US started to distribute American and European products in China. HOB has since established a large-scale, ISO 13485 certified manufacturing facility in Suzhou, China, producing high quality products for Asian markets ranging from Line Immuno Assay (LIA) to Enzyme-linked immunosorbent assay (ELISA). HOB has further established world-class R&D centers in Suzhou, China and California, US, with a well experienced product development team. Through this fundamental paradigm shift into emphasizing quality manufacturing and intensive R&D investment, HOB has arisen into the allergy & autoimmune diagnostic market leader in Asia and a global player in the IVD industry.

Based in Asia, Influencing the World

HOB’s mission is to establish and offer customers a top-tier brand in allergy and autoimmune in vitro diagnostics, with state-of-art technologies, the topnotch quality, and the cost effectiveness. As a leading manufacturer with strong R&D capability, HOB is expanding its global influence by forming strategic alliances with companies worldwide to provide advanced technology and the most competitive products.

The Future is Here

Allergies and autoimmune diseases affect hundreds of millions of people around the world, with more than 500 million affected in Asia alone. Serological tests render an irreplaceable value for the diagnosis of allergy and autoimmune diseases, yet have been monopolized by a few companies with outdated technologies and excessive costs. HOB is committed to offering advanced diagnostic solutions that will deliver greater value to healthcare providers and patients.

Recognizing unmet needs and the stagnant technology, HOB has developed and recently launched a patented, innovative, fully automated, and random-accessible platform, BioCLIA. BioCLIA is the result of extensive research and development by a team with decades of experience at leading companies. HOB BioCLIA assays implement the cutting-edge nanoparticle and chemiluminescent technology, and are the most advanced Chemiluminescent Immuno Assays (CLIA) available in the industry for allergy and autoimmune testing. Every six months, new products are released from the R&D pipeline to offer a wide selection of test menu items. BioCLIA is revolutionizing in vitro diagnostics for allergy and autoimmune disease by providing accurate results at a much faster speed, eliminating manual operations, and minimizing the financial burden on healthcare providers and patients.